Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19

BACKGROUND: Many treatments are being assessed for repurposing to treat coronavirus disease 2019 (COVID-19). One drug that has shown promising results in vitro is nitazoxanide. Unlike other postulated drugs, nitazoxanide shows a high ratio of maximum plasma concentration (C(max)), after 1 day of 500...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepperrell, Toby, Pilkington, Victoria, Owen, Andrew, Wang, Junzheng, Hill, Andrew M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332204/
https://www.ncbi.nlm.nih.gov/pubmed/32405422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332204/
https://www.ncbi.nlm.nih.gov/pubmed/32405422

Ejemplares similares